ClinicalTrials.Veeva

Menu

Hand Held Nitrous Oxide Delivery Device (HHN)

S

Strata Medical Innovations

Status

Unknown

Conditions

Anesthesia

Treatments

Other: There are no other inteventions.

Study type

Interventional

Funder types

Industry

Identifiers

NCT02119403
smi7531

Details and patient eligibility

About

To study the safety and efficacy of Hand Held Nitrous. A device that delivers 120 seconds of up to 72% nitrous oxide and ambient air.

Full description

This study assesses the Hand Held Nitrous Oxide Deliver Device which is intended to be used in nitrous oxide sedation systems by delivering a limited 16 grams of nitrous oxide over a total of 120 seconds of inhalation time.

The device creates short term minimal sedation by delivering a maximum 72% USP grade nitrous oxide / 28 % ambient air combination which quickly drops to under 33% nitrous oxide / 67% ambient air in 60 seconds and stays steady until all the gas is expelled.

Enrollment

250 estimated patients

Sex

All

Ages

3+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Any patient undergoing a painful office procedure or exam

Exclusion criteria

  • Women that are Pregnant
  • Children under three years of age

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

250 participants in 1 patient group

Hand Held NitrousTM
Experimental group
Description:
There are no other interventions to this device
Treatment:
Other: There are no other inteventions.

Trial contacts and locations

2

Loading...

Central trial contact

Mark W Aldana, B.S. MBA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems